PURPOSE/ OBJECTIVES: To assess the feasibility of auricular point acupressure to manage aromatase inhibitor-induced arthralgia. . DESIGN: Wait list control design. . SETTING: Outpatient clinics and oncology center. . SAMPLE: 20 women with aromatase inhibitor-induced arthralgia. . METHODS: After baseline data were collected, participants waited one month before they received acupressure once per week for four weeks at a convenient time. The baseline data served as the control comparison. Self-reported measures and blood samples were obtained at baseline, at preintervention, weekly during the intervention, and at post-intervention. . MAIN RESEARCH VARIABLES: The primary outcomes included pain intensity, pain interference, stiffness, and physical function. Inflammatory cytokines and chemokines were tested. . FINDINGS: After the four-week intervention, participants reported decreases in worst pain and pain interference, and improvements in physical function, cancer-related symptom severity, and interference. The proinflammatory cytokines and chemokines displayed a trend of a mean percentage reduction. The anti-inflammatory cytokine interleukin-13 increased from pre- to postintervention. . CONCLUSIONS: Auricular point acupressure is feasible and may be effective in managing arthralgia in breast cancer survivors. . IMPLICATIONS FOR NURSING: Nurses can administer acupressure in clinical settings, which could enhance the management of aromatase inhibitor-induced arthralgia and contribute to a shift from traditional disease-based biomedical models to a broader, integrative, medical paradigm for managing aromatase inhibitor-induced arthralgia.
PURPOSE/ OBJECTIVES: To assess the feasibility of auricular point acupressure to manage aromatase inhibitor-induced arthralgia. . DESIGN: Wait list control design. . SETTING:Outpatient clinics and oncology center. . SAMPLE: 20 women with aromatase inhibitor-induced arthralgia. . METHODS: After baseline data were collected, participants waited one month before they received acupressure once per week for four weeks at a convenient time. The baseline data served as the control comparison. Self-reported measures and blood samples were obtained at baseline, at preintervention, weekly during the intervention, and at post-intervention. . MAIN RESEARCH VARIABLES: The primary outcomes included pain intensity, pain interference, stiffness, and physical function. Inflammatory cytokines and chemokines were tested. . FINDINGS: After the four-week intervention, participants reported decreases in worst pain and pain interference, and improvements in physical function, cancer-related symptom severity, and interference. The proinflammatory cytokines and chemokines displayed a trend of a mean percentage reduction. The anti-inflammatory cytokine interleukin-13 increased from pre- to postintervention. . CONCLUSIONS: Auricular point acupressure is feasible and may be effective in managing arthralgia in breast cancer survivors. . IMPLICATIONS FOR NURSING: Nurses can administer acupressure in clinical settings, which could enhance the management of aromatase inhibitor-induced arthralgia and contribute to a shift from traditional disease-based biomedical models to a broader, integrative, medical paradigm for managing aromatase inhibitor-induced arthralgia.
Entities:
Keywords:
acupressure; aromatase inhibitor–induced arthralgia; breast cancer survivors
Authors: Jennifer Kawi; Chao Hsing Yeh; Nada Lukkahatai; Robin L Hardwicke; Thomas Murphy; Paul J Christo Journal: Evid Based Complement Alternat Med Date: 2022-08-29 Impact factor: 2.650
Authors: Chao Hsing Yeh; Keenan Caswell; Sonaali Pandiri; Haris Sair; Nada Lukkahatai; Claudia M Campbell; Vered Stearns; Barbara Van de Castle; Nancy Perrin; Thomas J Smith; Leorey N Saligan Journal: Glob Adv Health Med Date: 2020-02-13